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INTRODUCTION
The gene most commonly associated with congenital situs defects,
known as heterotaxy, in humans encodes the X-linked
transcription factor ZIC3 (MIM 306955). Mouse models of Zic3
dysfunction also result in heterotaxy, indicating conserved
mammalian function of this protein. Deletion of the entire ZIC3
locus in humans, or in the classical mouse mutant bent tail (Bn),
results in heterotaxy, indicating that loss-of-function is the most
likely pathogenic mechanism (Garber, 1952; Ferrero et al., 1997;
Gebbia et al., 1997; Carrel et al., 2000; Klootwijk et al., 2000). To
date, 12 ZIC3 variant sequences have also been identified in
heterotaxy-affected families: six missense, five nonsense and one
frameshift [caused by a two-nucleotide insert, which results in a
premature termination codon (PTC) 182 nucleotides upstream
from the wild-type transcription termination codon] (Gebbia et
al., 1997; Mégarbané et al., 2000; Ware et al., 2004; Chhin et al.,
2007). The functional significance of the 12 variant sequences has
been investigated in vitro using mutant proteins expressed from
ZIC3 full-length cDNAs containing each relevant mutation (Ware
et al., 2004; Chhin et al., 2007). The in vivo consequence of the
mutations that produce a PTC-containing transcript is, however,
hard to predict from these analyses. In vivo these mutant
transcripts might be subjected to nonsense-mediated decay
(NMD), whereas the cDNA variants used to model these mutations
would typically evade NMD, which, in mammalian cells, appears
dependent upon mRNA splicing (Neu-Yilik et al., 2001).
NMD is a method of gene regulation and surveillance that
recognizes and rapidly decays PTC-containing transcripts
(Frischmeyer and Dietz, 1999; Maquat, 2004). One purpose of
NMD is to limit the formation of C-terminally truncated
polypeptides that might possess deleterious gain-of-function or
dominant-negative activity. The mechanism by which a normal stop
codon is distinguished from a premature one appears dependent
upon the position of the PTC; a transcript will be committed to
decay if a PTC is situated more than about 50-55 nucleotides
upstream of an exon-exon junction (Nagy and Maquat, 1998).
Because the rules regarding PTC recognition are not completely
understood, the NMD sensitivity of PTC-containing transcripts
needs to be assessed on a case-by-case basis (Holbrook et al., 2004).
Moreover, not only do transcripts differ in their intrinsic sensitivity
to NMD, the efficiency of NMD with respect to a given transcript
can vary between tissues. To determine the functional significance
of a nonsense mutation, RNA and/or protein levels must therefore
be documented in the tissue and stage of development relevant to
the particular disorder (Bateman et al., 2003). For heterotaxy cases,
this requires assessing mRNA or protein levels at gastrulation (the
time of left-right axis formation); a task not possible for human
cases of heterotaxy. If the identified ZIC3 PTC-containing
transcripts evade NMD, they might code for a ZIC3 molecule with
a hypermorphic, hypomorphic or dominant-negative effect.
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SUMMARY
The ZIC transcription factors are key mediators of embryonic development and ZIC3 is the gene most commonly associated with situs defects
(heterotaxy) in humans. Half of patient ZIC3 mutations introduce a premature termination codon (PTC). In vivo, PTC-containing transcripts might be
targeted for nonsense-mediated decay (NMD). NMD efficiency is known to vary greatly between transcripts, tissues and individuals and it is possible
that differences in survival of PTC-containing transcripts partially explain the striking phenotypic variability that characterizes ZIC3-associated
congenital defects. For example, the PTC-containing transcripts might encode a C-terminally truncated protein that retains partial function or that
dominantly interferes with other ZIC family members. Here we describe the katun (Ka) mouse mutant, which harbours a mutation in the Zic3 gene
that results in a PTC. At the time of axis formation there is no discernible decrease in this PTC-containing transcript in vivo, indicating that the
mammalian Zic3 transcript is relatively insensitive to NMD, prompting the need to re-examine the molecular function of the truncated proteins
predicted from human studies and to determine whether the N-terminal portion of ZIC3 possesses dominant-negative capabilities. A combination
of in vitro studies and analysis of the Ka phenotype indicate that it is a null allele of Zic3 and that the N-terminal portion of ZIC3 does not encode
a dominant-negative molecule. Heterotaxy in patients with PTC-containing ZIC3 transcripts probably arises due to loss of ZIC3 function alone.
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There is some evidence from the study of Xenopus zic3 and
murine Zic2 that it is possible to produce a dominant-negative
Zic molecule (Kitaguchi et al., 2000; Elms et al., 2003; Brown et
al., 2005). The X-linked location of Zic3 in humans and mice
dictate, however, that the gene is not generally bi-allelically
expressed and it is therefore unlikely that the putative dominant-
negative activity could affect Zic3 function in vivo. Males are
hemizygous for the maternal copy of ZIC3, and females (after
random X-inactivation occurs in the embryo proper at
implantation) are chimeric for cells that express either the mutant
or the wild-type Zic3 allele. Zic3, however, shares significant
sequence homology with four other members of the mammalian
Zic gene family (Zic1, Zic2, Zic4 and Zic5) (Aruga et al., 1996a;
Aruga et al., 1996b; Furushima et al., 2000; Ali et al., 2012). The
five genes show extensive homology throughout the DNA binding
zinc fingers and Zic1, Zic2 and Zic3 also contain a conserved
region within the N-terminal portion of the protein called the
ZOC motif (Aruga et al., 2006). The coexpression of family
members could, therefore, enable a dominant-negative Zic3
molecule to interfere with the function of other Zic proteins. At
the time of axis formation, Zic3 is extensively coexpressed with
Zic2 and Zic5 (Furushima et al., 2000; Elms et al., 2004). Some
cases of heterotaxy could therefore result from a composite
phenotype due to deleterious effects on not only ZIC3 function
but also on one or more additional family members. This scenario
could partially explain the extreme phenotypic variability
associated with ZIC3 cases of heterotaxy (Ware et al., 2004).
Here, we show that the katun (Ka) mouse mutant (Bogani et al.,
2004) harbours a mutation in the Zic3 gene that introduces a PTC.
At the time of left-right axis formation, the mutant transcript is
not subjected to NMD, predicting the production of a mutant
protein during embryogenesis. When the analogous mutant cDNA
is expressed in cultured mammalian cell lines, a stable protein that
is truncated just two amino acids upstream of the zinc finger
domain is produced. The truncated protein lacks the zinc finger
domain and should fail to undergo nuclear import (Bedard et al.,
2007); however, it accumulates within the nucleus as a result of
passive diffusion. Despite its presence in the nucleus, the katun
protein is unable to elicit transcription of a ZIC3 target promoter
and does not compete with the wild-type trans-activation ability
of the ZIC3, ZIC2 or ZIC5 proteins, indicating that the N-terminal
portion of ZIC3 does not possess dominant-negative activity.
Additionally, the katun protein fails to inhibit Wnt-mediated
transcription, unlike wild-type ZIC3 protein. The phenotype of
katun mutant embryos replicates that of a targeted null allele of
Zic3 and confirms that the Ka mutant phenotype results from a
loss of Zic3 activity alone.
The relative ability of a transcript to undergo NMD is influenced
by sequences within the transcript that promote RNA splicing, such
as splice donor and acceptor sites (Gudikote et al., 2005). The
murine Zic3 and human ZIC3 transcripts contain identical splice
sites so the finding that the murine Zic3 transcript is relatively
insensitive to NMD during axis formation and early organogenesis
suggests that the human transcript also evades NMD at these stages
of embryogenesis. This prompted the examination of other
truncated ZIC3 proteins predicted in human heterotaxy cases and
none were found to possess dominant-negative activity. The data
suggest that ZIC3-associated heterotaxy caused by nonsense or
frameshift mutations affects ZIC3 function alone. The katun
mutant is useful not only for investigations into the molecular
mechanisms underlying ZIC3-associated heterotaxy but also for
studies of Zic protein interaction and transcriptional surveillance
mechanisms.
RESULTS
The Zic3 gene is mutated in the katun mouse strain
The katun allele arose as a spontaneous, X-linked mutation during
an N-ethyl-N-nitrosourea (ENU) mutagenesis experiment (Bogani
et al., 2004), indicating that it might be a new allele of Zic3, the
gene deleted in the classical, X-linked mouse mutant bent tail (Bn)
(Carrel et al., 2000; Klootwijk et al., 2000) and mutated in targeted
mouse strains (Purandare et al., 2002; Zhu et al., 2007). The coding
region of Zic3 was amplified from the genomic DNA of a
heterozygous female, a hemizygous male, a C3H mouse and a
BALB/c mouse and sequenced. This revealed a single base change
of guanine (G) to thymine (T) at nucleotide position 1283 (1283G
>T) of accession number NM_009575 in the affected animals
(Fig. 1A-C). The colony has subsequently been maintained via
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TRANSLATIONAL IMPACT
Clinical issue
Heterotaxy, or situs ambiguous, refers to a group of rare congenital defects that
are characterized by abnormal organ distribution. In heterotaxy, the normal,
asymmetric position of organs (known as situs solitus) is disrupted, and this
typically causes severe congenital heart disease that is sometimes
accompanied by malformation of other organs. The most commonly mutated
gene in heterotaxy is ZIC3, which encodes an X-linked transcription factor that
plays a role in embryonic development. Half of the heterotaxy-associated ZIC3
mutations identified to date introduce a premature termination codon (PTC)
and the aberrant transcripts are expected to undergo nonsense-mediated
decay (NMD). NMD of PTC-containing mRNAs varies in a transcript-, tissue- and
stage-dependent manner and incomplete NMD can produce truncated
proteins of unknown function. The presence of truncated proteins with varied
functional abilities could underlie the remarkable phenotypic diversity
observed in cases of heterotaxy.
Results
This study utilizes a novel model of murine Zic3 dysfunction, called katun,
which harbours a point mutation that introduces a premature stop codon into
the Zic3 transcript. Based on the presence of this PTC, the transcript was
predicted to undergo NMD. However, the authors show that at the embryonic
stage of left-right axis formation (during which organ asymmetry is
established), the transcript evades NMD and a stable truncated protein is
generated. They show that the truncated protein lacks endogenous function
yet does not interfere with other coexpressed Zic proteins. The authors’
analysis of all known PTC-containing ZIC3 mutations provided the same result:
all of the truncated proteins behaved as partial or complete loss-of-function
mutants that did not interfere with wild-type ZIC3 function.
Implications and future directions
These results suggest that ZIC3-associated heterotaxy arises due to partial or
complete loss of ZIC3 function, and not as a consequence of dominant-
negative effects. The work also demonstrates the importance of investigating
whether PTC-incorporating mutations lead to NMD in vivo (at the relevant
stage and in the appropriate tissue type), rather than assuming that PTC-
containing transcripts will be subject to NMD and will generate a null allele.
The katun mouse strain will serve as a useful model for further investigations
into the molecular pathways underlying ZIC3-associated heterotaxy, and for
studies of Zic protein interactions and transcriptional surveillance mechanisms.
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genotyping of this variant, and non-segregation between the
phenotype and mutation found in more than 1000 meioses. A
further five strains of mice (Mus Castaneus, Mus Spretus, C57BL/6J,
129Sv and 101/H) were analysed and none were found to contain
the variant allele, eliminating the possibility that the variant is a
naturally occurring polymorphism. The identified base change
introduces a PTC at amino acid 249 (E249X) and, if translated,
would cause termination of the protein sequence just two amino
acids upstream of the zinc finger domain (Fig. 1D).
The katun transcript evades nonsense-mediated decay
The katun transcript conforms to the rule for NMD (Nagy and
Maquat, 1998) and is predicted to be absent from hemizygous
null embryos. To determine whether the katun transcript is
subjected to NMD we performed whole mount in situ
hybridization (WMISH) to Zic3 in wild-type and Ka/Y embryos
(7.0, 8.5, and 9.5 days post-conception; dpc). As shown in Fig. 2A-
E, Zic3 transcript levels were indistinguishable from wild-type
levels in the hemizygous null embryos at all stages examined,
suggesting that NMD of the Ka transcript is deficient. To confirm
this, allele-specific RT-PCR was performed at each of the
embryonic stages examined by WMISH from embryos of all three
genotypes (+/+, Ka/X and Ka/Y). The absence of genomic DNA
in each sample was confirmed by amplification of an intron
spanning fragment from the Zic3 gene. The 162-bp cDNA-
specific product was only amplified from cDNA samples
synthesized in the presence of reverse transcriptase, whereas the
1006-bp genomic DNA-specific product was absent in all samples
(Fig. 2F and data not shown). Allele-specific RT-PCR products
were then produced (using exon 1 primers) from each RNA
sample and analysed by high resolution melt analysis. In each case,
the melt profile of the products obtained from cDNA samples
was compared with positive control profiles obtained from
genomic DNA of animals of known genotype (Fig. 2G). At 7.5,
8.5 and 9.5 dpc, embryos containing only the mutant Zic3 allele
(Zic3Ka/Y) exclusively express the Ka transcript, embryos
containing only the normal Zic3 allele (Zic3+/+) exclusively express
the wild-type transcript whereas embryos with one mutant and
one wild-type allele (Zic3Ka/X) express a mixture of the two
transcripts (Fig. 2G-J). The hybridization signal seen in Zic3Ka/Y
mutant embryos is therefore due to the accumulation of the Ka
transcript. Together, these data indicate that the Ka transcript is
not rapidly subjected to NMD during axis formation (the stage
at which the Zic3-associated heterotaxy phenotype emerges).
The mutant protein is stable and accumulates in the nucleus via
passive diffusion
The finding of incomplete NMD raises the possibility that the
message could be translated into a short-lived, truncated protein
with some function. Detection of Zic3 protein in wild-type and
katun mutant embryos using SDS-PAGE and western blotting was
not successful due to failure of the antibodies to specifically detect
endogenous Zic3 (data not shown). Therefore, to determine
whether this mutant Zic3 transcript can be translated into a stable
protein, either a N-terminal V5-epitope tagged version of ZIC3 (V5-
ZIC3-wt) or ZIC3-katun variant (V5-ZIC3-katun) were expressed
in cultured mammalian cell lines. Following transfection of COS-
7, HEK293T or NIH 3T3 cells a wild-type protein of ~60 kDa and
a katun protein of ~35 kDa were detected with western blotting
using either an anti-Zic3 antibody or an anti-V5 antibody. Both
proteins were detected in lysates made 24, 42 and 72 hours post-
transfection, indicating that the katun protein is stable (Fig. 3A and
data not shown). The predicted sizes of the wild-type and katun
ZIC3 proteins are 52  kDa and 27  kDa, respectively, with the
difference corresponding to the size of the V5 tag and spacer
fragment within the pcDNA3.1/nV5-DEST vector.
The Zic3 protein does not contain a canonical nuclear
localization signal but is transported into the nucleus via the
importin pathway through cryptic nuclear localization signals
within the zinc finger domain (Bedard et al., 2007; Hatayama et al.,
2008). The absence of the zinc finger domain in the katun protein
is therefore expected to prevent accumulation of V5-ZIC3-katun
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Fig. 1. The katun mouse strain carries
a mutation in Zic3. (A-C)Sequence
traces from exon 1 of the murine Zic3
gene, with arrows indicating the
altered base. (A)The parental C3H/HeH
and BALB/c OlaHsd alleles have a G at
position 1283 of accession number
NM_009575. (B)Female carriers of the
mutation have a G/T heteroduplex at
this position. (C)Male hemizygotes
have a G to T transversion at this
position. (D)Representation of the Zic3
protein showing the position of the
katun (E249X) mutation relative to
other protein features, including the
C2H2 zinc fingers (dark blue), amino
acid repeat regions (blue; A, alanine
repeat; H, histidine repeat), the Zic-Opa
conserved (ZOC) motif (bright green)
and the zinc finger N-flanking
conserved (ZF-NC) region (light green).
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within the nucleus. As shown in Fig. 3A, subcellular fractionation
of transfected cell lysates revealed that a significant proportion of
the katun protein was found in the nucleus. To confirm this result
and quantify the extent of katun nuclear accumulation, the
subcellular localization of V5-ZIC3-katun was compared with that
of V5-ZIC3-wt by immunofluorescent staining following
transfection into HEK293T cells (Fig.  3B,D). Consistent with
previous studies on the subcellular location of Zic proteins (Ware
et al., 2004), 88.5% of the wild-type V5-ZIC3-wt protein was found
within the nucleus. Strikingly, 61.4% of the mutant V5-ZIC3-katun
dmm.biologists.org758
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Fig. 2. The katun PTC-containing transcript accumulates in gastrulation and organogenesis stage mutant embryos. (A-E)Lateral views of embryos after
WMISH to Zic3 RNA; embryos are shown with anterior to the left (A,B,D,E) or top (C). (A,B)7.0 dpc embryos of the genotype indicated on the panel. (C)8.5 dpc
embryos of the genotype indicated on the panel. (D,E)9.5 dpc embryos of the genotype indicated on the panel. (F)PCR amplification of an intron-spanning
product from the Zic3 gene (generated with primers Ark364 and Ark311; expected product size for genomic DNA is 1006 bp and for cDNA is 162 bp) following
cDNA synthesis from each of the RNAs used for allele-specific PCR. –RT, without reverse transcriptase; +RT, with reverse transcriptase; g, genomic DNA; n, no
template control; m, size marker. (G-J)Melting peak analysis following high resolution melting of Zic3 allele-specific PCR products (generated with primers
Ark1085 and Ark1086). The Zic3+/+ DNA melt profiles are shown in gray, the Zic3Ka/Y DNA melt profiles in blue and the Zic3Ka/X profiles in red. (G)Zic3 amplicons
after PCR of genomic DNA isolated from three Zic3+/+ mice, three Zic3Ka/X mice or three Zic3Ka/Y mice. (H)Zic3 amplicons after PCR of cDNAs synthesized from
7.5 dpc RNA. (I)Zic3 amplicons after PCR of cDNAs synthesized from 8.5 dpc RNA. (J)Zic3 amplicons after PCR of cDNAs synthesized from 9.5 dpc RNA.
(K)Diagram of the murine Zic3 genomic locus showing the location of the mutation and the primers used for allele-specific and intron-spanning RT-PCR.
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protein accumulated within the nucleus. This raised the possibility
that the N-terminal portion of Zic3 contains sequences sufficient
for directed nuclear transport. It is, however, also possible that the
small size of the katun protein enables it to diffuse into the nucleus
because proteins smaller than ~40 kDa can diffuse into the nucleus
(Wei et al., 2003). To distinguish between these possibilities, the
size of the katun protein was artificially increased by fusion with
enhanced green fluorescent protein (EGFP). The subcellular
localization of EGFP-ZIC3-katun was compared with that of EGFP-
ZIC3-wt following transfection into HEK293T cells using western
blot and immunofluorescent staining (Fig.  3B-D). Western blot
analysis detected EGFP-ZIC3-wt in the nuclear fraction at ~85 kDa
(predicted size, 79  kDa) and EGFP-katun predominately in the
cytoplasmic fraction at ~55  kDa (predicted size, 54  kDa).
Immunofluorescent localization analysis found that 88.9% of the
EGFP-ZIC3-wt protein was within the nucleus, whereas only
10.3% of the mutant EGFP-ZIC3-katun protein accumulated within
the nucleus. The difference between the localization of the V5-
ZIC3-katun protein and the EGFP-ZIC3-katun protein suggests
that the katun protein accumulates in the nucleus by passive
diffusion.
The mutant protein is transcriptionally inactive and does not
compete with wild-type ZIC3
Given that the katun protein is stable and localizes to the nucleus,
it is possible that the protein exerts some effect. The zinc finger
domain is crucial for the trans-activation ability of Zic proteins
because deletion of the domain or point mutations within the zinc
fingers that disrupt DNA binding leads to proteins that are unable
to stimulate transcription (Brown et al., 2005). The ability of V5-
ZIC3-katun to stimulate transcription was evaluated using a well-
established cell-based Apoe promoter luciferase reporter assay
(Salero et al., 2001; Brown et al., 2005). Co-transfection of the Apoe
reporter construct with either the V5-ZIC3-wt construct or the
V5-ZIC3-katun construct into HEK293T cells followed by
quantification of luciferase activity demonstrated that the truncated
protein was unable to elicit transcription (Fig. 4A). The comparable
expression of each ZIC3 construct was confirmed by SDS-PAGE
and western blot (Fig. 4A, Blot). When V5-ZIC3-katun was placed
in competition with wild-type ZIC proteins (V5-ZIC3-wt, V5-
ZIC2-wt or V5-ZIC5-wt) the trans-activation abilities of the wild-
type proteins were not significantly altered (Fig. 4B).
The mutant protein does not inhibit β-catenin-mediated
transcription
The human ZIC2 and Xenopus zic1-5 proteins have recently been
shown to act as cofactors that inhibit Wnt-dependent-β-catenin-
mediated transcription (Pourebrahim et al., 2011; Fujimi et al.,
2012). Upon Wnt stimulation, β-catenin enters the nucleus and
interacts with the TCF transcription factors to stimulate
transcription of target genes (Behrens et al., 1996). A luciferase
reporter construct containing consensus TCF binding sites
(TOPflash) or mutated TCF sites (FOPflash) is routinely used to
assess Wnt-dependent transcription (Korinek et al., 1997). Co-
transfection of the TOPflash construct with one encoding a
stabilized form of β-catenin (β-catenin-ΔN89) into HEK293T cells
drove high levels of luciferase activity (Fig. 4C) but this level was
not attained in the presence of V5-ZIC3-wt. This indicates that
human ZIC3, like ZIC2, is able to inhibit β-catenin-mediated
transcription of Wnt target genes in cultured HEK293T cells. In
addition, when ZIC3 is expressed, lower levels of β-catenin-ΔN89
are detected, which is consistent with the enhanced β-catenin
degradation previously seen with the expression of Xenopus zic3
(Fujimi et al., 2012). In contrast to wild-type ZIC3 protein, co-
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Fig. 3. Truncated katun protein diffuses
into the nucleus. (A)HEK293T cells
expressing either V5-ZIC3-wt or V5-ZIC3-
katun were lysed to generate nuclear (N)
and cytoplasmic (C) fractions. Lysates were
then subjected to SDS-PAGE and western
blotting with anti-V5 antibodies.
(B)HEK293T cells expressing V5- or EGFP-
tagged ZIC3 constructs were co-
immunostained with anti-lamin B antibody
(to detect nuclear envelope, in red) and
either anti-V5 or anti-GFP antibodies (in
green). Overlaid images are shown.
(C)HEK293T cells expressing either EGFP-
ZIC3-wt or EGFP-ZIC3-katun were lysed and
fractionated into nuclear (N) and
cytoplasmic (C) fractions. Lysates were then
subjected to SDS-PAGE and western
blotting with anti-GFP antibodies.
(D)Localization of V5-ZIC3-wt or V5-ZIC3-
katun in nuclear (gray) and cytoplasmic
(black) compartments of HEK293T cells was
quantified using ImageJ. *P<0.01 using
ANOVA.
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transfection with V5-ZIC3-katun does not decrease luciferase
activity, indicating that the katun protein is unable to inhibit Wnt-
dependent β-catenin-mediated transcription.
Ka phenocopies a targeted null allele of Zic3
The most definitive test of allele type involves placing the new allele
in trans to a known null allele, but this test cannot be performed
dmm.biologists.org760
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Fig. 4. The katun protein is functionally inert. (A)Trans-activation assay in HEK293T cells co-transfected with the Apoe reporter construct and the expression
plasmids shown. The anti-V5 western blot shows the level of overexpressed proteins and the anti-TBP western blot acts as a nuclear fraction loading control.
(B)Competition assay in HEK293T cells co-transfected with the Apoe reporter construct and the expression plasmids shown. The anti-V5 western blot shows the
level of overexpressed proteins and the anti-TBP western blot acts as a loading control. (C)Wnt inhibition assay in HEK293T cells co-transfected with either
TOPflash or FOPflash reporter construct and the expression plasmids shown. The anti-V5 and anti-β-catenin western blots show the level of overexpressed
proteins in the nuclear and cytoplasmic fractions, respectively. The anti-TBP and anti-β-tubulin western blots act as nuclear and cytoplasmic loading controls,
respectively. Anti-β-catenin detects both endogenous β-catenin and the smaller exogenously expressed β-catenin-ΔN89 (marked by arrows). Error bars denote
s.d. between internal replicates; *P<0.01 using ANOVA.
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
for X-linked genes. To determine whether the Ka allele of Zic3
behaves as a null mutation in vivo we therefore recovered embryos
at gastrulation stages and examined the associated phenotype. The
allele of Zic3 that is best characterized at these stages is the targeted
null allele of Zic3 (Zic3tm1Bca) (Purandare et al., 2002). Embryos
from this strain that are hemizygous or homozygous null have a
variable phenotype, with mutant embryos being assigned to three
classes. Type I and Type II embryos display aberrant morphology
at early and mid-gastrula stages, whereas the Type III embryos are
not morphologically abnormal until the end of gastrulation. The
Type I and Type II embryos are characterized by defects in the
endoderm and mesoderm formed during gastrulation (Ware et al.,
2006b). When embryos hemizygous for the Ka allele (Zic3Ka/Y) were
recovered at gastrulation a highly variable phenotype was apparent.
A proportion of the recovered embryos displayed defects of the
distal egg cylinder or of the extra-embryonic/embryonic junction
that are characteristic of the Type I and Type II embryos, as
described previously (Ware et al., 2006b). 100% of these embryos
were of the Zic3Ka/Y genotype.
To confirm that the phenotype observed in the Zic3Ka/Y embryos
is analogous to that described for embryos from the targeted null
allele, WMISH to markers of endoderm and mesoderm formation
was performed (a minimum of four embryos were examined per
genotype class and probe). Embryos that had morphological defects
characteristic of type I mutants were analysed by hybridization to
probes to detect Cer1 and Lim1 expression (Fig. 5A,B). At this stage
of development, both of these genes are expressed in the anterior
visceral endoderm (AVE) at the embryonic anterior (arrows in
Fig. 5A,B). This expression was either lacking or markedly reduced
in all mutant embryos examined. Cer1 is also expressed in the
emerging definitive endoderm and Lim1 is expressed in the wings
of developing embryonic mesoderm and this expression was also
disrupted in Type I Zic3Ka/Y embryos (Fig. 5A,B). Embryos that had
morphological defects characteristic of Type II embryos were
analysed by hybridization to probes that mark the primitive streak
and emerging wings of embryonic mesoderm (Fgf8 and Foxa2).
Consistent with previous analysis (Ware et al., 2006b), Type II
embryos exhibited mesoderm abnormalities that included a
protrusion of the primitive streak into the amniotic cavity (Fig. 5C)
and ectopic expression of mesoderm markers (arrows in Fig. 5D,E).
Additional embryos (n=65 Zic3+/+ and n=27 Zic3Ka/Y) were recovered
at 9.5 dpc and the heart examined for looping defects indicative of
heterotaxy. Consistent with previous analysis of a Zic3 null allele
(Ware et al., 2006a), 52% of null embryos exhibited normal hearts
(dextral looping, Fig. 5F), 19% exhibited a leftward curve of the heart
tube (sinistral looping, Fig. 5G) and the remaining 30% had a heart
tube that looped forward (ventral looping) or did not loop at all.
PTC-containing ZIC3 mutant transcripts produce proteins that do
not compete with wild-type ZIC3
The magnitude of NMD is dependent upon the strength of the splice
donor and acceptor sites within an intron, with stronger sites (i.e.
those that more closely match the consensus sequence) subject to
increased NMD (Gudikote et al., 2005). To assess whether inefficient
NMD of the human ZIC3 can be predicted, the mouse Zic3 and
human ZIC3 splice sites were compared. As shown in Table 1, the
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Fig. 5. The katun mutant embryos have altered primitive
streak, mesoderm and endoderm formation. (A-G)All
embryos are shown in lateral view, anterior to the left, following
in situ hybridization to the RNA named on each panel. (A)Wild-
type and type I mutant embryo, 7.0 dpc. (B)Wild-type and type I
mutant embryo, 7.0 dpc. Arrows in A and B mark the anterior
visceral endoderm (AVE). (C)Wild-type and type II mutant
embryo, 7.5 dpc. (D)Wild-type and type II mutant embryo,
7.0 dpc. (E)Wild-type and type II mutant embryo, 7.0 dpc. Arrows
in D and E point to regions of ectopic expression of mesoderm
markers. (F,G)Developing hearts of 9.5-dpc embryos of the
genotype indicated (photographed following in situ
hybridization to mRNAs not expressed in the heart; the signal
seen is nonspecific). R, right ventricle; L, left ventricle.
Table 1. Zic3/ZIC3 splice site homology and scores 
 
Donor site Acceptor site 
Sequence (5′-3′) CV Sequence (5′-3′) CV 
Murine Zic3 Intron 1/2 CAGgtaagg 98.07 tgccttttgcagGT 92.14 
Human ZIC3 CAGgtaagg tgccttttgcagGT 
Murine Zic3 Intron 2/3 AAGgtaatt 86.73 tgttaattttagGT 82.17 
Human ZIC3 AAGgtaatt tgttaattttagGT 
Murine Zic3 Intron 2/4 AAGgtaatt 86.73 ttttcttgccagTG 90.41 
Human ZIC3 AAGgtaatt tttttttgccagTG 89.80 
Splice site consensus values (CV) were calculated using Human Splicing Factor (http://www.umd.be/HSF/4DACTION/input_SSF). Upper case letters indicate exon sequence; lower 
case letters indicate intron sequence. 
Gene                                                     Intron
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sites are identical (intron 1/2 and 2/3) or nearly so (intron 2/4). Intron
2/3 has the weakest splice signals, as indicated by a lower consensus
value score. The absolute conservation of Zic3 and ZIC3 splice sites
prompted the examination of the predicted proteins from each of
the ZIC3-associated heterotaxy mutations that generate a PTC. Six
different ZIC3-associated heterotaxy mutations with a PTC have
been previously documented and the protein stability, subcellular
localization and transcriptional ability of each of these has been
assessed using cell-based assays. Two of these mutations generate
unstable proteins (S43X and Q249X) whereas the remaining
mutations generate stable proteins that can either be found
exclusively in the cytoplasm (C268X and Q292X) or in both
cytoplasmic and nuclear compartments (1507insTT and K408X)
(Ware et al., 2004). To test whether any of these proteins possess
dominant-negative properties, the analogous mutant proteins were
expressed in HEK293T in competition with wild-type ZIC3.
Expression of each ZIC3 construct was verified by SDS-PAGE and
western blot of lysates containing both nuclear and cytoplasmic
fractions. Note that the Q249X mutation was excluded from this
analysis because it is probably well-modelled by experiments with
the V5-ZIC3-katun construct. Our results confirm the finding of
Ware and colleagues that the K408X protein retains some trans-
activation ability (Ware et al., 2004). Importantly, co-transfection of
each ZIC3 mutant construct (V5-ZIC3-C268X, V5-ZIC3-Q292X,
V5-ZIC3-1507insTT and V5-ZIC3-K408X) with wild-type ZIC3 (V5-
ZIC3-wt) demonstrated that none of the mutant proteins significantly
alter the ability of wild-type ZIC3 to activate transcription (Fig. 6).
DISCUSSION
The katun mouse strain carries a null allele of Zic3
The katun mouse strain arose spontaneously during an ENU-
mutagenesis experiment (Bogani et al., 2004). We show here that
the identified phenotype (a bent tail) is caused by mutation of the
X-linked Zic3 gene. Several lines of evidence indicate that the
identified mutation is responsible for the phenotype: (i) the
identified base pair change is not a commonly occurring
polymorphism; (ii) the variant segregates with the phenotype, being
linked through over 1000 meioses to date during maintenance of
the colony; (iii) the identified nonsense mutation generates an
inactive protein; and (iv) the phenotype precisely recapitulates that
documented for a pre-existing null allele of Zic3.
The katun mutation introduces a nonsense codon into the Zic3
transcript that conforms to the rule for PTC recognition in
mammalian cells. This provides the first opportunity to investigate
the fate of such Zic3 transcripts during mammalian axis formation.
WMISH to Zic3 in Ka/Y embryos at gastrulation and early
organogenesis stages showed no decrement in Zic3 mRNA
accumulation. Allele-specific RT-PCR confirmed that the only
transcript expressed in Ka/Y embryos carries the nonsense mutation
and that both wild-type and mutant transcripts are present in Ka/X
embryos. These data indicate that the Zic3 transcript is a poor
substrate for NMD at the time of left-right axis formation and raise
the possibility that the Ka mutation does not represent a null allele.
Investigations into the molecular properties of the katun mutant
protein confirmed, however, that it lacks activities associated with
wild-type ZIC3. The katun protein is truncated just two amino acid
residues upstream of the zinc finger domain that is required for
nuclear localization (Bedard et al., 2007; Hatayama et al., 2008), trans-
activation of target gene expression (Koyabu et al., 2001; Mizugishi
et al., 2001; Ware et al., 2004) and inhibition of β-catenin-mediated
transcription (Fujimi et al., 2012). Although katun can accumulate
in the nucleus to appreciable levels (due to passive diffusion rather
than active transport), it is transcriptionally inert and does not inhibit
β-catenin-mediated transcription.
These data establish that the katun protein is null for the known
Zic3 molecular activities, but Xenopus experiments have implied
that a similar zic3 protein interferes with the function of wild-type
zic3 during axis formation (Kitaguchi et al., 2000). This possibility
has not previously been biochemically tested. When the katun
mutant protein is placed in competition with either wild-type ZIC3
or the other ZIC molecules coexpressed at the time of axis
formation (ZIC2 and ZIC5), it does not interfere with their ability
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Fig. 6. ZIC3-heterotaxy-associated mutant
proteins do not compete with wild-type ZIC.
Competition assay using HEK293T cells co-
transfected with the Apoe reporter construct and
the expression plasmids shown. The anti-V5 western
blot shows the level of overexpressed proteins and
the anti-TBP western blot acts as a loading control.
Arrow marks the position of V5-ZIC3-wt in the blot.
Error bars denote s.d. between internal replicates. a,
P<0.01 using ANOVA, compared with V5-ZIC3-wt. b,
P<0.001 using ANOVA, compared with V5-ZIC3-wt
and other ZIC3 mutants.
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to activate transcription of a target promoter in HEK293T cells.
More rigorous evidence that the katun protein does not dominantly
interfere with the activity of other Zic proteins comes from the in
vivo studies presented here. Experiments that decrease Zic2 activity
in a Zic3 null background indicate that these two molecules exhibit
partial redundancy during murine axis formation (Inoue et al.,
2007). If the katun protein interferes with Zic2 function in vivo
then the Ka strain should exhibit a more severe phenotype than
other known Zic3 null alleles. Analysis of the phenotype of the Ka/Y
embryos shows that it mimics a null allele of Zic3 in several precise
details and indicates that that the Ka allele alters the function of
Zic3 alone. Together, the phenotype and protein studies
demonstrate that Ka encodes a null allele of Zic3 and that the N-
terminal portion of mammalian Zic3 does not encode a dominant-
negative molecule.
The possibility of incomplete NMD influences the interpretation of
ZIC3 PTC-inducing mutations
The finding that the murine Zic3 transcript is a poor substrate for
NMD at axis formation suggests that this is also the case for the
human ZIC3 transcript. Direct assessment of the fate of human
ZIC3 PTC-containing transcripts during axis formation is not
possible and predictions regarding the likely NMD behaviour
based on the murine transcript provide one alternative. The
features that render a transcript a poor target for NMD are not
fully characterized. There is, however, evidence that the position
of the PTC within the transcript and RNA splicing influences NMD
amplitude (Nagy and Maquat, 1998; Gudikote et al., 2005). The
genomic arrangement of the murine (Zic3) and human (ZIC3)
genes is nearly identical and the splice donor and acceptor sites are
completely conserved. It is likely that the human ZIC3 transcript
is similarly able to avoid mRNA surveillance mechanisms, which
needs to be considered when interpreting the probable effect of
ZIC3 PTC-inducing mutations. If PTC-containing transcripts are
translated, the two most likely effects are: (i) proteins that truncate
downstream of crucial domains might be hypomorphic; and (ii)
proteins that do not produce crucial domains might encode
dominant-negative molecules.
Six mutations that introduce a PTC into the human ZIC3
transcript have been associated with congenital defects. Four of
these adhere to the position rule for NMD (i.e. the PTC is sited
more than  about 50-55 nucleotides upstream of an exon-exon
junction (Nagy and Maquat, 1998). The most 5-ward of the
mutations (C633A) would encode a severely truncated molecule
(S43X) if not degraded. Previous examination of this putative
protein has shown that it is not stably produced in cell lines (Ware
et al., 2004) and is therefore likely to generate a null allele regardless
of NMD amplitude. The C1250T mutation would encode the
Q249X protein. An expression construct incorporating this
mutation into the ZIC3 cDNA has previously been reported to
produce no protein (Ware et al., 2004). This PTC lies very close to
that generated here in order to mimic the katun protein (E250X),
but the katun mutation results in a stable protein. Whatever the
reason for the discrepancy between these results, the studies of the
katun protein suggest that even if the Q249X protein is generated
in vivo it would encode a protein with neither transcriptional Wnt
inhibition nor dominant-negative activity. The remaining two
mutations (C1338A and C1408T) that conform to the NMD PTC
position rule would generate proteins that contain part of the zinc
finger domain (C268X and Q292X, respectively). Previous studies
indicate that these proteins are transcriptionally inactive and here
we confirm and extend this analysis to show that these proteins
also fail to dominantly interfere with ZIC trans-activation ability.
It seems likely that each of these four mutations would generate a
null allele of ZIC3 regardless of NMD amplitude and not result in
a composite ZIC phenotype. The remaining two mutations
(1507insTT and A1741T) introduce a PTC close to the last intron
and, regardless of ZIC3 transcript sensitivity to NMD, are likely to
be translated into a stable protein. Here, we confirm that the
frameshift protein is transcriptionally inert whereas the K408X
protein (corresponding to the A1741T mutation) retains some
trans-activation ability. Neither protein is able to interfere with the
trans-activation ability of wild-type ZIC. The frameshift mutation
therefore appears to generate a null allele whereas the K408X
mutation is predicted to be hypomorphic. This conclusion is
consistent with the finding of incomplete penetrance for the
A1741T mutation (Mégarbané et al., 2000).
In summary, the work presented here confirms the notion that
loss of function (partial or complete) of ZIC3 alone is the probable
mode of pathology in ZIC3-associated heterotaxy cases that involve
PTC-containing transcripts. It implies, however, that ZIC3 PTC-
inducing mutations cannot, a priori, be considered to encode a null
allele. It is possible that the ZIC3 transcript, like Zic3, is a poor
substrate for NMD at the axis formation stage of embryogenesis.
Instead, each putative protein needs to be evaluated for its trans-
activation ability, co-repressor ability and potential dominant-
negative effects. Analysis of the phenotype associated with a
murine PTC-containing transcript suggests that the N-terminal
portion of the Zic3 protein that lies upstream of the zinc finger
does not possess dominant-negative activity and does not interfere
with the function of other coexpressed Zic proteins.
MATERIALS AND METHODS
Mouse strains and husbandry
Mice were maintained according to Australian Standards for
Animal Care under protocol A2011/63 approved by The Australian
National University Animal Ethics and Experimentation Committee
for this study. The katun (Ka) allele (MGI:3043027) of Zic3 (Zic3Ka)
was maintained by continuous backcross to C57BL/6J inbred mice;
animals from backcross 10 and beyond were used for analysis. Mice
were maintained in a 12-hour light-dark cycle, the midpoint of the
dark cycle being 1 am. For the production of staged embryos, 1 pm
on the day of appearance of the vaginal plug was designated 0.5
dpc. Genomic DNA was prepared for genotyping as previously
described (Arkell et al., 2001) and amplified for high resolution melt
analysis using IMMOLASE™ DNA polymerase with TD60 PCR
thermal cycling conditions (Thomsen et al., 2012). The Ka mice
and embryos were genotyped using the primers Ark1085_F 5-
CCTTCTTCCGTTACATGCG-3 and Ark1086_R 5-CTGAGC -
CTCCTCGATCC-3 and sexed using primers Ark1002_F 5-
GAGGTCATGAAGGTCAG-3 and Ark1003_R 5-GGGCATAA -
ACTTTCCAG-3.
Mutation detection
Mutation detection was performed by direct sequencing of PCR
amplicons from genomic DNA isolated from affected animals and
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the appropriate parental strains (C3H/HeH and BALB/c OlaHsd)
(Bogani et al., 2004). All primers correspond to intron sequence
such that coding sequence and intron/exon boundaries were
examined for mutations. The oligonucleotides used for sequencing
Zic3 were: fragment 1, Ark207_F 5-TAGGAAAGTTGCAGCTCC-
3 and Ark208_R 5-ATAGTTAGGGAACTGCGC-3; fragment 2,
Ark209_F 5-CTACTTGCTCTTTCCTGG-3 and Ark210_R 5-
TGGTACTGAAAGGTCTCG-3; fragment 3, Ark211_F 5-
CAGATGCTATGTCCTTCC-3 and Ark212_R 5-TTCAAGGT -
GTCAGTGCTG-3; fragment 4, Ark213_F 5-CTAGGGGTA -
TCTATCTCG-3 and Ark214_R 5-CTGAGAAAAGGGCAT -
AGC-3.
Whole mount in situ hybridization and cDNA clones
All embryos were dissected from the maternal membranes in PBS
with 10% newborn calf serum and staged using morphological
criteria (Downs and Davies, 1993). Embryos were fixed overnight
at 4°C in 4% paraformaldehyde in PBS. WMISH was carried out
according to standard procedures (Wilkinson, 1992; Rosen and
Beddington, 1994). Probes for WMISH were as previously
described: Zic3 (Elms et al., 2004), Lhx1 (Shawlot and Behringer,
1995), Cer1 (Belo et al., 1997), Foxa2 (Sasaki and Hogan, 1993) and
Fgf8 (Mahmood et al., 1995). After completion of the WMISH,
embryos were de-stained in PBT (PBS with 0.1% Tween-20) for
48 hours and post-fixed in 4% paraformaldehyde in PBS for 1 hour
at room temperature. Embryos were processed for photography
through a glycerol series (50%, 80% and 100%) and photographed
on a glass slide.
RT-PCR
Embryos, dissected and staged, for RT-PCR were individually frozen
in 96-well plates on dry ice and stored at −70°C. Upon geno- and
sex-typing of the corresponding embryo tissue, the embryos were
pooled in three genotype classes (Zic3+/+, Zic3Ka/X and Zic3Ka/Y).
Each pool consisted of ten embryos at 7.5 dpc, four embryos at 8.5
dpc and two embryos at 9.5 dpc. Genomic DNA-free RNA was
extracted from each sample using the Ambion RNAqueous 4 PCR
kit (Life Technologies). RNA concentration was quantified by
Nanodrop spectrophotometry and 500  ng of RNA template
included in a random primed cDNA first strand synthesis reaction
(Superscript VILO cDNA synthesis kit; Life Technologies). A RT
negative control synthesis reaction was performed in parallel from
each RNA sample. To confirm absence of contaminating genomic
DNA in the original RNA samples, amplification from each cDNA
sample was performed using primers Ark364 and Ark311 (located
in exons 2 and 3, respectively, of Zic3) using Abgene DNA
polymerase (with buffer: 10 mM Tris-HCl, pH 8.3, at 25°C, 50 mM
KCl, 1.5 mM MgCl2) and TD60 PCR thermal cycling conditions
with an extension time of 45 seconds (Thomsen et al., 2012). PCR
products were analysed by agarose gel electrophoresis.
Amplification from genomic DNA produces a 1006-bp product
whereas that from cDNA results in a 162-bp product. For allele-
specific PCR, each cDNA (0.5 μl) was used in the genotyping assay.
Plasmids
All plasmid construction used standard molecular biology
procedures. The Gateway® Recombination Cloning Technology
(Life Technologies™) was used to generate V5-epitope-tagged
expression plasmids. The appropriate cDNA was transferred to the
pENTR™3C vector that had been linearized with EcoRI (NEB) and
dephosphorylated with Antarctic Phosphatase (NEB) to produce
an ‘entry’ clone. Four entry clones were generated as follows.
pENTR™3C-ZIC3-wt: a full length ZIC3 cDNA was recovered
from the HA-ZIC3-wt expression plasmid (a gift from Stephanie
Ware, Cincinnati Children’s Hospital Medical Center, OH) (Ware
et al., 2004) by PCR with oligonucleotides Ark1152_F 5-
ATCCGGTACCGAATTCACCCTCTCTCACTTCGG-3 and
Ark1153_R 5-GTGCGGCCGCGAATTCCCGCTCTAGAAC -
TAGTGG-3. This amplicon was cloned using In-Fusion™ Dry-
Down PCR Cloning System (Clontech) into pENTR™3C vector (Life
Technologies).
pENTR™3C-ZIC3-katun: the HA-ZIC3-wt plasmid was 
subjected to site-directed mutagenesis with the QuikChange® II
Site-Directed Mutagenesis Kit (Stratagene) using oligonucleotides
Ark1006_F 5-GCCTATCAAGCAGTAGCTGTCGTGCAAGTG-
3 and Ark1007_R 5-CACTTGCACGACAGCTACTGCTTG -
ATAGGC-3. The ZIC3-katun cDNA was amplified and cloned as
for ZIC3-wt into pENTR™3C.
pENTRTM3C-ZIC2-wt: a full length ZIC2 cDNA was PCR
amplified from pcDNA-ZIC2 (a gift from Maral Mouradian, Robert
Wood Johnson Medical School, NJ) (Yang et al., 2000), using
oligonucleotides: Ark1150_F 5-ATCCGGTACCGAATTCAGTG -
TGGTGGAATTCCTGGCC-3 and Ark1168_R 5-GTGCGGCC -
GCGAATTCGAGGGTTAGGGA TAGGCTTAC-3 and cloned
into pENTR™3C using the In-Fusion™ Dry-Down PCR Cloning
System.
pENTR™3C-ZIC5-wt: a full length ZIC5-wt cDNA was excised
from pCMV6-XL5-ZIC5 (Origene) via EcoRI digestion and ligated
into pENTR™3C using T4 DNA ligase (NEB). Entry clones for all
other ZIC3 mutant plasmids were created via site-directed
mutagenesis of pENTR™3C-ZIC3-wt with the QuikChange II Site-
Directed Mutagenesis Kit (Stratagene). Primers used to introduce
mutations were as follows: pENTR™3C-ZIC3-C268X, Ark1399_F
5-CGGCCCAAGAAGAGCTGAGACCGGACCTTCAGC-3 and
Ark1400_R GCTGAAGGTCCGGTCTCAGCTCTTCTTGGGC -
CG-3; pENTR™3C-ZIC3-Q292X, Ark1401_F 5-GTGGGGGG -
CCCGGAGTAGAACAACCACGTCTGC-3 and Ark1402_R 
5-GCAGACGTGGTTGTTCTACTCCGGGCCCCCCAC-3;
pENTR™3C-ZIC3-1507insTT, Ark1403_F 5-CCGAGTGC -
ACACGGGCTTGAGAAGCCCTTCCCA-3 and Ark1404_R 
5-TGGGAAGGGCTTCTCAAGCCCGTGTGCACTCGG-3;
pENTR™3C-ZIC3-K408X, Ark1405_F 5-CTGCGCAAACAC -
ATGTAGGTTCATGAATCTCAA-3 and Ark1406_R 5-TTGA -
GATTCATGAACCTACATGTGTTTGCGCAG-3.
In each case, the inserts from the entry clones were transferred
to the destination clone pcDNA3.1/nV5-DEST™ (Life Technologies)
via a Gateway® LR Clonase reaction (as per manufacturer’s
instructions; Life Technologies) to produce the following plasmids:
V5-ZIC3-wt, V5-ZIC3-katun, V5-ZIC3-C268X, V5-ZIC3-Q292X,
V5-ZIC3-1507insTT, V5-ZIC3-K408X, V5-ZIC2-wt and V5-ZIC5-
wt. To generate the EGFP-tagged ZIC3 constructs, ZIC3 was
amplified from HA-ZIC3-wt or HA-ZIC3-katun using the following
primers: Ark1208_F 5-GAGCTCAAGCTTCGAATTCTACCC -
TCTCTCACTTCGG-3 and Ark1209_R 5-TACCGTCGAC -
TGCAGAATTCCCGCTCTAGAACTAGTG-3. The PCR product
was cloned into pEGFP-C1 (linearized with EcoRI and
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dephosphorylated with Antartic Phosphatase) using the In-Fusion™
Dry-Down PCR Cloning System. The Apoe reporter construct
pXP2-Apoe (−189/+1) was a gift from Francisco Zafra (Centro de
Biología Molecular, Universidad Autonoma de Madrid, Spain)
(Salero et al., 2001). The TOPflash and FOPflash vectors contain
four optimal TCF binding sites or four mutant TCF binding sites,
respectively, upstream of a minimal c-Fos promoter and luciferase
cDNA. These vectors and the pCAN-β-catenin-ΔN89 expression
construct (Munemitsu et al., 1996) were a gift from Sabine Tejpar
(Molecular Digestive Oncology, Katholieke Universiteit Leuven,
Belgium) (Pourebrahim et al., 2011).
Cell culture and transfection
Mammalian cell lines COS-7, NIH3T3 and HEK293T were cultured
in Dulbecco’s modified Eagle’s medium (DMEM) (Life
Technologies), supplemented with 10% (v/v) fetal bovine serum
(Life Technologies), 2  mM L-glutamine (Life Technologies) and
0.1 mM non-essential amino acid solution (Life Technologies) at
37°C in humidified air. For transient transfections, cells were
transfected with either 0.4-0.6  μg or 3-4  μg of the mammalian
expression plasmid DNA using Lipofectamine™ 2000 (Life
Technologies) according to the manufacturer’s guidelines.
Immunofluorescence staining, microscopy and quantification of
subcellular localization
Cells were prepared for immunofluorescence microscopy as
previously described (Kovacs et al., 2002) and viewed using the LSM
5 Pascal (ZEISS) confocal microscope. At least 100 transfected cells
per experiment were scored blind as follows. For each cell, the
nuclear and cytoplasmic compartment was traced using the Intuos®
2 graphics tablet (Wacom) and the average fluorescence intensity
for each compartment of the cell was measured with ImageJ analysis
software (NIH). The values from the 100 scored cells were averaged
to give the percentage nuclear and percentage cytoplasmic
localization for the experiment. Three independent experiments
were conducted and the percentage localization in each cellular
compartment averaged across the three experiments. For statistical
analysis, GenStat (VSN International) was used to perform a non-
orthogonal factorial ANOVA. Images were assembled in Adobe
Photoshop CS7.
Subcellular fractionation, SDS-PAGE and western blotting
HEK293T cells grown on 35-mm tissue culture dishes or 12-well
tissue culture plates (Corning®) were lysed and fractioned into
nuclear and cytoplasmic fractions using the NE-PER kit (Pierce)
according to the manufacturer’s protocol. CERI and NERI lysis
buffers were supplemented with protease inhibitors (complete,
EDTA-free protease inhibitor cocktail, Roche). Then, 2 mM DTT
(Sigma Aldrich) and 1× NuPAGE LDS Sample Buffer (Life
Technologies) were added to nuclear and cytoplasmic fractions
and the samples heated for 5 minutes at 90°C. Samples were then
loaded onto 8%, 10% or 12% SDS-PAGE gels and run at 100 V.
Proteins were transferred to PVDF membranes (Millipore) via wet
transfer at 15 V for 16 hours. Membranes were blocked overnight
at 4°C with a solution of 5% skim milk powder, PBS and 0.2%
Tween 20 (Sigma Aldrich) (western blot blocking buffer) before
being immunoblotted using standard western blotting techniques.
To detect protein bands, blots were incubated with SuperSignal
West Pico reagent (as per manufacturer’s guidelines; Pierce) then
exposed to film (Amersham Hyperfilm MP, GE Life Sciences).
Developed films were scanned and assembled in Adobe Illustrator
CS5.1.
Antibodies
Primary antibodies used were: goat polyclonal anti-Zic3 N-19 (1:500
dilution for western blot; Santa Cruz Biotechnology, sc-28154),
mouse monoclonal anti-HA (1:100 dilution for
immunofluorescence, 1:4000 dilution for western blot; Sigma,
H3663), mouse monoclonal anti-V5 (1:200 dilution for
immunofluorescence, 1:3000 dilution for western blot; Life
Technologies, R960-25), rabbit polyclonal anti-GFP (1:300 dilution
for immunofluorescence, 1:1000 dilution for western blot; Cell
Signaling, 2555), rabbit polyclonal anti-Lamin B1 (1:1000 dilution
for immunofluorescence; Abcam, ab16048), mouse monoclonal
anti-β-tubulin (1:1000 dilution for western blot; Abcam, ab7792),
mouse monoclonal anti-TATA binding protein (TBP) (1:2000
dilution for western blot; Abcam, ab818) and goat polyclonal β-
catenin C-18 (1:500 dilution for western blot; Santa Cruz
Biotechnology, sc-1496). Secondary antibodies used for
immunofluorescence (all at 1:500 dilution) were Alexa-Fluor-594-
and Alexa-Fluor-488-conjugated donkey anti-mouse, anti-goat and
anti-rabbit (Molecular Probes, Life Technologies). Secondary
antibodies used for western blot (all at 1:5000 dilution) were
horseradish peroxidase-conjugated rabbit anti-mouse, rabbit anti-
goat and goat anti-rabbit (Zymed, Life Technologies). All antibodies
were diluted in blocking buffer.
Luciferase reporter assays
HEK293T cells grown in 12-well tissue culture plates were
transfected with the relevant combination of constructs. For ZIC
trans-activation assays, a total of 1.2  μg of DNA was added per
well: 0.6 μg of the Apoe reporter construct and either 0.6 μg of the
expression construct or the negative control construct,
pcDNA3.1/nV5-DEST™. For ZIC competition assays, a total of
1.2  μg of DNA was added per well: 0.4  μg of the Apoe reporter
construct, 0.4 μg of the wild-type ZIC expression construct and
0.4 μg of either the competing katun expression construct or the
pcDNA3.1/nV5-DEST™ vector when required to equalize the
amount of transfected DNA. For the Wnt inhibition assays, a total
of 1.5 μg of DNA was transfected per well: 0.5 μg of the TOPflash
or FOPflash reporter vectors, 0.5 μg β-catenin-ΔN89 construct and
0.5  μg of the appropriate ZIC3 construct or pcDNA3.1/nV5-
DEST™. To assess background Wnt activation levels, one well was
transfected with 0.5  μg of the TOPflash or FOPflash reporter
vectors and 1  μg of the pcDNA3.1/nV5-DEST™ vector. Either
8 hours (for the ZIC trans-activation and competition assays) or
5.5  hours (for the Wnt inhibition assays) post-transfection, cells
were dissociated from the growth surface using 0.05  g/l trypsin
(Life Technologies) and plated in triplicate onto a solid white tissue-
culture treated 96-well plate (Costar®, CLS3917). To avoid any
position bias error of the luminometer, sample order was
randomized for each independent experimental repeat. The
remaining cells were re-plated for SDS-PAGE and western blot
analysis and lysed at the time of the reporter assay. Either 16 (for
ZIC trans-activation and competition assays) or 19.5 hours (for Wnt
inhibition assays) after re-plating, cells in each well were lysed by
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incubation with 100 μl of a 1:1 dilution of luciferase substrate (ONE-
Glo™ Luciferase Assay System, Promega) with DMEM and the
luminescence from each well measured in a GloMax®-96 Microplate
Luminometer (Promega). The luciferase activity was normalized
to the pcDNA3.1/nV5-DEST™ negative control and the average
value and standard deviation calculated from the three internal
repeats. At least three independent experiments were performed
for each assay, with one representative experiment shown. For
statistical analysis, GenStat was used to perform ANOVA with
Fischer’s unprotected post ad hoc test.
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